[1]瞿玮颖,邱仲川,陈珮,等.复方参鹿颗粒干预钙结合蛋白S100A8/A9改善较低危骨髓增生异常综合征患者无效造血机制研究[J].中国中医药信息杂志,2019,26(9):20-24.[doi:10.3969/j.issn.1005-5304.2019.09.006]
 QU Weiying,QIU Zhongchuan,CHEN Pei,et al.Study on Mechanism of Intervention of Compound Shenlu Granules in S100A8/A9 for Improving Ineffective Hematopoiesis in Patients with Lower-risk Myelodysplastic Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2019,26(9):20-24.[doi:10.3969/j.issn.1005-5304.2019.09.006]
点击复制

复方参鹿颗粒干预钙结合蛋白S100A8/A9改善较低危骨髓增生异常综合征患者无效造血机制研究

参考文献/References:

[1] 林果为,欧阳仁荣,陈珊珊,等.现代临床血液病学[M].上海:复旦大学出版社,2013:907-908.

[2] CHEN X, EKSIOGLU E A, ZHOU J, et al. Induction of myelodysplasia by myeloid-derived suppressor cells[J]. J Clin Invest,2013, 123(11):4595-4611.

[3] HERMANI A, DE SERVI B, MEDUNJANIN S, et al. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells[J]. Exp Cell Res,2006,312(2):184-197.

[4] 赵琳,邱仲川,江秀花,等.复方补肾冲剂治疗肾阳虚型骨髓增生异常综合征的研究[J].上海医学,2006,29(3):147-149.

[5] 张旭峰,赵琳,徐培.从p38MAPK通路探讨复方参鹿颗粒对较低危MDS骨髓患者CD34+细胞凋亡的影响[J].中国实验方剂学杂志,2017, 23(16):152-157.

[6] 中华医学会血液学分会.骨髓增生异常综合征诊断与治疗专家共识[J].中华血液学杂志,2012,33(4):347-352.

[7] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:178-179.

[8] 张之南.血液病诊断及疗效标准[M].北京:科学出版社,1998:259.

[9] ISHIBASHI M, TAMURA H, OGATA K. Disease progression mechanism in myelodysplastic syndromes:insight into the role of the microenvironment[J]. Leuk Res,2011,35(11):1449-1452.

[10] KORNDÖRFER I P, BRUECKNER F, SKERRA A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins[J]. J Mol Biol,2007,370(5):887-898.

[11] CLUZEAU T, MCGRAW K L, IRVINE B, et al. Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes[J]. Haematologica, 2017,102(12):2015-2020.

[12] LEONI C, MONTAGNER S, RINALDI A, et al. Dnmt3a restrains mast cell inflammatory responses[J]. Proc Natl Acad Sci USA,2017, 114(8):E1490-E1499.

[13] LEE S C, DVINGE H, KIM E, et al. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins[J]. Nat Med,2016,22(6):672-678.

[14] NAVAS T A, MOHINDRU M, ESTES M, et al. Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors[J]. Blood,2006,108(13):4170-4177.

[15] VARNEY M E, MELGAR K, NIEDERKORN M, et al. Deconstructing innate immune signaling in myelodysplastic syndromes[J]. Exp Hematol, 2015,43(8):587-598.

相似文献/References:

[1]马俊丽,曲文闻,胡晓梅.含砷中药复方青黄散治疗骨髓增生异常综合征的克隆选择性与砷体内效应的相关性研究[J].中国中医药信息杂志,2013,20(6):8.[doi:10.3969/j.issn.1005-5304.2013.06.004]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(9):8.[doi:10.3969/j.issn.1005-5304.2013.06.004]
[2]周庆兵,胡晓梅,刘峰,等.骨髓增生异常综合征中医药研究进展[J].中国中医药信息杂志,2012,19(4):101.[doi:10.3969/j.issn.1005-5304.2012.04.050]
[3]宋敏敏,王月,方苏,等.胡晓梅温阳化毒治疗骨髓增生异常综合征经验[J].中国中医药信息杂志,2014,21(8):109.[doi:10.3969/j.issn.1005-5304.2014.08.035]
 [J].zhongguo zhongyiyao xinxi zazhi,2014,21(9):109.[doi:10.3969/j.issn.1005-5304.2014.08.035]
[4]赵琳,邱仲川,陈珮,等.复方参鹿颗粒治疗肾阳虚型再生障碍性贫血疗效观察及对CD4+T细胞亚群的影响[J].中国中医药信息杂志,2016,23(5):20.[doi:10.3969/j.issn.1005-5304.2016.05.006]
 ZHAO Lin,QIU Zhong-chuan,CHEN Pei,et al.Efficacy Observation of Fufang Shenlu Granule for Kidney-yang Deficiency Aplastic Anemia and Its Effects on CD4+ T Lymphocyte Subsets[J].zhongguo zhongyiyao xinxi zazhi,2016,23(9):20.[doi:10.3969/j.issn.1005-5304.2016.05.006]
[5]邓中阳,方苏,王洪志,等.含砷中药复方青黄散安全有效治疗骨髓增生异常综合征方法研究[J].中国中医药信息杂志,2017,24(10):22.[doi:10.3969/j.issn.1005-5304.2017.10.006]
 DENG Zhong-yang,FANG Su,WANG Hong-zhi,et al.Study on Safe and Effective Clinical Methods for Arsenic-containing Compound Qinghuang Powder in Treatment of Myelodysplastic Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2017,24(9):22.[doi:10.3969/j.issn.1005-5304.2017.10.006]

备注/Memo

基金项目:国家自然科学基金青年基金(81403233)

更新日期/Last Update:

2019-08-11